Apeloa Pharmaceutical (SHE:000739) signed a strategic cooperation framework agreement for the outsourced customized production (CDMO) project.
Under the agreement, the pharmaceutical company and Jixing Hong Kong will continuously improve product market competitiveness and stable supply capabilities, and share benefits, according to a Friday filing with the Shenzhen bourse.
Apeloa Pharmaceutical will carry out the research and development and production of the CDMO project based on the parties' master service agreement.
Shares of the company rose 3% in recent trade.